MetaChip provides quick, efficient toxicity screening of potential drugs

Researchers at the University of California, Berkeley, and Rensselaer Polytechnic Institute have created a biotech chip that mimics the metabolic reactions in the human liver, allowing rapid screening of potential drugs to identify those activated by the liver and to weed out those made toxic.
"The MetaChip would allow testing a backlog of compounds for toxicity earlier in the drug discovery process – faster and more efficiently – and help remove a current bottleneck in the drug discovery process," said Douglas S. Clark, professor of chemical engineering at UC Berkeley.

Full story »

All News summaries from General Science news
All News summaries for January 21, 2005